Natural history of Crohn's disease following total colectomy and end ileostomy

Inflammatory Bowel Diseases

Volumn 20, Issue 7, 2014, Pages 1236-1241

  Lopez, Joanna ^a   Konijeti, Gauree G ^a   Nguyen, Deanna D ^a,b   Sauk, Jenny ^a,b   Yajnik, Vijay ^a,b   Ananthakrishnan, Ashwin N ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Crohn's disease; Ileostomy; Postoperative; Recurrence

Indexed keywords

TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ALGORITHM; ARTICLE; CROHN DISEASE; FEMALE; HUMAN; ILEOSTOMY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; TERTIARY CARE CENTER; TOTAL COLON RESECTION; TREATMENT OUTCOME; COHORT ANALYSIS; COLON RESECTION; CONFIDENCE INTERVAL; DISEASE COURSE; EVALUATION STUDY; FOLLOW UP; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TIME FACTOR; YOUNG ADULT;

ADULT; COHORT STUDIES; COLECTOMY; CONFIDENCE INTERVALS; CROHN DISEASE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; ILEOSTOMY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TERTIARY CARE CENTERS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84905511233     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000072     Document Type: Article

References (36)

1. Baumgart DC, Sandborn WJ. Crohn's disease. Lancet. 2012;380:1590-1605.
2. Bernstein CN, Loftus EV Jr, Ng SC, et al. Hospitalisations and surgery in Crohn's disease. Gut. 2012;61:622-629.
3. Ramadas AV, Gunesh S, Thomas GA, et al. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates. Gut. 2010;59:1200-1206.
4. Lakatos PL, Golovics PA, David G, et al. Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009. Am J Gastroenterol. 2012;107:579-588.
5. Loftus EV Jr, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther. 2002;16:51-60.
6. Renna S, Camma C, Modesto I, et al. Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in postoperative Crohn's disease. Gastroenterology. 2008;135:1500-1509.
7. Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn's disease. Gastroenterology. 1990;99:956-963.
8. Rutgeerts P, Geboes K, Vantrappen G, et al. Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut. 1984;25:665-672.
9. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease. Br J Surg. 2000;87:1697-1701.
10. Olaison G, Smedh K, Sjodahl R. Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms. Gut. 1992;33:331-335.
11. Buisson A, Chevaux JB, Bommelaer G, et al. Diagnosis, prevention and treatment of postoperative Crohn's disease recurrence. Dig Liver Dis. 2012;44:453-460.
12. Hashash JG, Regueiro MD. The evolving management of postoperative Crohn's disease. Expert Rev Gastroenterol Hepatol. 2012;6:637-648.
13. Ng SC, Kamm MA. Management of postoperative Crohn's disease. Am J Gastroenterol. 2008;103:1029-1035.
14. Amiot A, Gornet JM, Baudry C, et al. Crohn's disease recurrence after total proctocolectomy with definitive ileostomy. Dig Liver Dis. 2011;43:698-702.
15. Bernell O, Lapidus A, Hellers G. Recurrence after colectomy in Crohn's colitis. Dis Colon Rectum. 2001;44:647-654; discussion 654.
16. Fichera A, McCormack R, Rubin MA, et al. Long-term outcome of surgically treated Crohn's colitis: a prospective study. Dis Colon Rectum. 2005;48:963-969.
17. Leal-Valdivieso C, Marin I, Manosa M, et al. Should we monitor Crohn's disease patients for postoperative recurrence after permanent ileostomy? Inflamm Bowel Dis. 2012;18:E196.
18. Yamamoto T, Keighley MR. Long-term outcome of total colectomy and ileostomy for Crohn disease. Scand J Gastroenterol. 1999;34:280-286.
19. de Silva PS, Nguyen DD, Sauk J, et al. Long-term outcome of a third anti-TNF monoclonal antibody after the failure of two prior anti-TNFs in inflammatory bowel disease. Aliment Pharmacol Ther. 2012;36:459-466.
20. Desai A, Zator ZA, de Silva P, et al. Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:309-315.
21. Oxford EC, Nguyen DD, Sauk J, et al. Impact of coexistent celiac disease on phenotype and natural history of inflammatory bowel diseases. Am J Gastroenterol. 2013;108:1123-1129.
22. Zator ZA, Cantu SM, Konijeti GG, et al. Pretreatment 25-hydroxyvitamin D levels and durability of anti-tumor necrosis factor-alpha therapy in inflammatory bowel diseases. JPEN J Parenter Enteral Nutr. 2014;38:385-391.
23. Nalichowski R, Keogh D, Chueh HC, et al. Calculating the benefits of a research patient data repository. AMIA Annu Symp Proc. 2006:1044.
24. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2-6; discussion 16-9.
25. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749-753.
26. Onali S, Petruzziello C, Calabrese E, et al. Frequency, pattern, and risk factors of postoperative recurrence of Crohn's disease after resection different from ileo-colonic. J Gastrointest Surg. 2009;13:246-252.
27. Regueiro M, Schraut W, Baidoo L, et al. Infliximab prevents Crohn's disease recurrence after ileal resection. Gastroenterology. 2009;136:441-450. e1; quiz 716.
28. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg. 2000;231:38-45.
29. Cho SM, Cho SW, Regueiro M. Postoperative management of Crohn disease. Gastroenterol Clin North Am. 2009;38:753-762.
30. Doherty G, Bennett G, Patil S, et al. Interventions for prevention of postoperative recurrence of Crohn's disease. Cochrane Database Syst Rev. 2009:CD006873.
31. Greenstein AJ, Lachman P, Sachar DB, et al. Perforating and nonperforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut. 1988;29:588-592.
32. Spinelli A, Sacchi M, Fiorino G, et al. Risk of postoperative recurrence and postoperative management of Crohn's disease. World J Gastroenterol. 2011;17:3213-3219.
33. Beaugerie L, Seksik P, Nion-Larmurier I, et al. Predictors of Crohn's disease. Gastroenterology. 2006;130:650-656.
34. de Bie CI, Paerregaard A, Kolacek S, et al. Disease phenotype at diagnosis in pediatric Crohn's disease: 5-year analyses of the EUROKIDS Registry. Inflamm Bowel Dis. 2013;19:378-385.
35. Solberg IC, Cvancarova M, Vatn MH, et al. Risk matrix for prediction of advanced disease in a population-based study of patients with Crohn's disease (the IBSEN study). Inflamm Bowel Dis. 2014;20:60-68.
36. Nunes T, Etchevers MJ, Domenech E, et al. Smoking does influence disease behaviour and impacts the need for therapy in Crohn's disease in the biologic era. Aliment Pharmacol Ther. 2013;38:752-760.